Skip to main content

Advertisement

SpringerLink
Log in

Hamartomatous Polyposis Syndromes: Molecular Genetics, Neoplastic Risk, and Surveillance Recommendations

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Hamartomatous polyposis syndromes are characterized by an overgrowth of cells or tissues native to the area in which they normally occur. Juvenile polyposis syndrome (JPS) results from germ-line mutations in the SMAD-4 gene (18q21.1) that encodes for an enzyme involved in transforming growth factor beta(TGF-β) signal transduction. The increased neoplastic risk may result from SMAD-4 mutations in the stromal component, which stimulate epithelial dysplasia and progression to invasive malignancy. Peutz-Jeghers syndrome (PJS) is associated with germ-line mutations in the LKB1 gene (19p13.3) that encodes a multifunctional serine-threonine kinase. These mutations occur in the epithelial component, suggesting a direct tumor suppressor effect. Patients are at an increased risk of intestinal and extraintestinal malignancies, including breast, pancreatic, ovarian, testicular, and cervical cancer. Cowden’s disease is associated with germ-line mutations in the PTEN gene (10q22–23) and an increased risk of breast and thyroid malignancies. Ruvalcaba-Myhre-Smith syndrome is less common; controversy suggests that it may represent a variant of Cowden’s disease.

Conclusions: Genetic alterations underlying hamartomatous polyposis syndromes are diverse. Carcinogenesis may result from either germ-line mutations in the stroma (JPS) or as a direct result of functional deletion of tumor suppressor genes (PJS). Diagnosis depends on clinical presentation and patterns of inheritance within families. Suggested surveillance guidelines for the proband and first-degree relatives are outlined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986; 10: 871–87.

    CAS  PubMed  Google Scholar 

  2. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9: 138–41

    PubMed  CAS  Google Scholar 

  3. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998; 280: 1036–7.

    PubMed  CAS  Google Scholar 

  4. McColl I, Bussey HJR, Veale AMO, Morrison BC. Juvenile polyposis coli. Proc R Soc Med 1964; 57: 896–7.

    PubMed  CAS  Google Scholar 

  5. Desai DC, Neale KF, Talbot IC, Hodgson SV, Phillips RKS. Juvenile polyposis. Br J Surg 1995; 82: 14–17.

    PubMed  CAS  Google Scholar 

  6. Giardiello FM, Hamilton SR, Kern SE. Colorectal neoplasia in juvenile polyposis or juvenile polyposis. Arch Dis Child 1991; 66: 971–5.

    Article  PubMed  CAS  Google Scholar 

  7. Sachatello CR, Hahn IS, Carrington CB. Juvenile gastrointestinal polyposis in a female infant: Report of a case and review of the literature of a recently recognized syndrome. Surgery 1974; 75: 107–14.

    PubMed  CAS  Google Scholar 

  8. Jacoby RF, Schlack S, Cole CE, Skarbek M, Harris C, Meisner LF. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology 1997; 112: 1398–403.

    PubMed  CAS  Google Scholar 

  9. Olschwang S, Serova-Sinilnikova OM, Lenoir GM, Gilles T. PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998; 18: 12–14.

    PubMed  CAS  Google Scholar 

  10. Liaw D, Marsh DJ, LiJ, et al. Germ-line mutations of the PTEN gene in Cowden’s disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16: 64–7.

    Article  CAS  PubMed  Google Scholar 

  11. Marsh DJ, Dahia PLM, Coulon V, et al. Germ-line mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997; 16: 333–4.

    PubMed  CAS  Google Scholar 

  12. Dahia PLM, Marsh DJ, Zheng Z, et al. Somatic deletions and mutations in the Cowden Disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 1997; 57: 4710–13.

    PubMed  CAS  Google Scholar 

  13. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280: 1086–8.

    PubMed  CAS  Google Scholar 

  14. Jass JR, Williams CB, Bussay HJR, Morson BC. Juvenile polyposis-a precancerous condition. Histopathology 1988; 13: 619–30.

    Article  CAS  PubMed  Google Scholar 

  15. Bevan S, Woodford-Richens K, Rozen P, et al. Screening SMAD1, SMAD2, SMAD3 and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut 1999; 45: 406–8.

    Article  PubMed  CAS  Google Scholar 

  16. Coburn MC, Pricolo VE, DeLuca FG, Bland KI. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995; 2: 386–91.

    CAS  PubMed  Google Scholar 

  17. Howe JR, Ringold JC, Hughes JH, Summers RW. Direct genetic testing for SMAD4 mutations in patients at risk for juvenile polyposis. Surgery 1999; 126: 162–70.

    PubMed  CAS  Google Scholar 

  18. Peutz JLA. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane. Nederl maandschr v geneesk 1921; 10: 134–46.

    Google Scholar 

  19. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N Engl J Med 1949; 241: 993–1005.

    Article  PubMed  CAS  Google Scholar 

  20. Guillem JG, Smith AJ, Puig-La Calle J, Ruo L. Hamartomatous polyposis. In: Wells SA, Creswell LL, eds. Gastrointestinal Polyposis Syndromes. St Louis: Mosby Inc, 1999: 286–99.

    Google Scholar 

  21. Hemminki A, Tomlinson I, Markie D, et al. Localization of a susceptibility locus for Peutz-Jegher’s syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997; 15: 87–90.

    PubMed  CAS  Google Scholar 

  22. Wang ZJ, Ellis I, Zauber P. Allelic imbalance at the LKB1 (STK11) locus on 19p13.3 in hamartomas, adenomas and carcinomas from patients with Peutz-Jegher’s syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J Pathol 1999; 188: 613–17.

    Google Scholar 

  23. Esteller M, Avizienyte E, Corn PG, et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 2000; 19: 164–8.

    PubMed  CAS  Google Scholar 

  24. Giardiello FM, Welsh SW, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316: 1511–14.

    Article  PubMed  CAS  Google Scholar 

  25. Spigelman AD, Murday V, Phillips RKS. Cancer and the Peutz-Jeghers syndrome. Gut 1989; 30: 1588–90.

    PubMed  CAS  Google Scholar 

  26. Hizawa K, Iida M, Matsumoto T, et al. Cancer in Peutz-Jeghers syndrome. Cancer 1993; 72: 2777–81.

    PubMed  CAS  Google Scholar 

  27. Reid JD. Intestinal carcinoma in the Peutz-Jeghers syndrome. JAMA 1974; 229: 833–4.

    PubMed  CAS  Google Scholar 

  28. Spigelman AD, Arese P, Phillips RKS. Polyposis: the Peutz-Jeghers syndrome. Br J Surg 1995; 82: 1311–14.

    PubMed  CAS  Google Scholar 

  29. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for familial breast cancer risk: A guide for clinicians. JAMA 1995; 273: 577–85.

    PubMed  CAS  Google Scholar 

  30. Lloyd KM II, Dennis M. Cowden’s disease: A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58: 136–42.

    PubMed  Google Scholar 

  31. Thyresson HN, Doyle JA. Cowden’s disease (multiple hamartoma syndrome). Mayo Clin Proc 1981; 56: 179–84.

    PubMed  CAS  Google Scholar 

  32. Eng C. Cowden syndrome. J Genet Counseling 1997; 6: 181–91.

    Google Scholar 

  33. Marsh DJ, Kum JB, Lunetta KL, Bennett, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 1999; 8: 1461–72.

    PubMed  CAS  Google Scholar 

  34. Nelen MR, Padberg GW, Peeters EAJ, et al. Localization of the gen for Cowden disease to chromosome 10q22–23. Nat Genet 1996; 13: 114–16.

    PubMed  CAS  Google Scholar 

  35. Marsh DJ, Zheng Z, Zedenius J, et al. Differential loss of heterozygosity in the region of the Cowden locus within 10q22–23 in follicular thyroid adenomas and carcinomas. Cancer Res 1997; 57: 500–3.

    PubMed  CAS  Google Scholar 

  36. Steck P, Perhouse M, Jasser SA, et al. Identification of a candidate suppressor gene MMAC1 at chromosome 10q22–23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356–62.

    Article  CAS  PubMed  Google Scholar 

  37. LiJ, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997; 275: 1943–6.

    PubMed  CAS  Google Scholar 

  38. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997; 57: 3660–3.

    PubMed  CAS  Google Scholar 

  39. Hanssen AMN, Fryns JP. Cowden syndrome. J Med Genet 1995; 32: 117–9.

    Article  PubMed  CAS  Google Scholar 

  40. Starink TM, van der Veen JPW, Arwert F de Waal LP, et al. The Cowden syndrome. A clinical and genetic study in 21 patients. Clin Genet 1986; 29: 222–33.

    Article  PubMed  CAS  Google Scholar 

  41. Longy M, Lacombe D. Cowden disease. Report of a family and review. Ann Genet 1996; 39: 35–42.

    PubMed  CAS  Google Scholar 

  42. Ruvalcaba RH, Myhre S, Smith DW. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet 1980; 18: 413–6.

    Article  PubMed  CAS  Google Scholar 

  43. Gorlin RJ, Cohen MM Jr, Condon LM, Burke BA. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1992; 44: 307–14.

    PubMed  CAS  Google Scholar 

  44. Zigman AF, Lavine JE, Jones MC, Boland CR, Carethers JM. Localization of the Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23. Gastroenterology 1997; 113: 1433–7.

    PubMed  CAS  Google Scholar 

  45. Carethers JM, Furnari FB, Zigman AF, et al. Absence of PTEN/MMAC1 germline mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res 1998; 58: 2724–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, New York

    Debrah A. Wirtzfeld MD, FRCSC, Nicholas J. Petrelli MD & Miguel A. Rodriguez-Bigas MD

  2. Division of Surgical Oncology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY, 14263

    Miguel A. Rodriguez-Bigas MD

Authors
  1. Debrah A. Wirtzfeld MD, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas J. Petrelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel A. Rodriguez-Bigas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel A. Rodriguez-Bigas MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wirtzfeld, D.A., Petrelli, N.J. & Rodriguez-Bigas, M.A. Hamartomatous Polyposis Syndromes: Molecular Genetics, Neoplastic Risk, and Surveillance Recommendations. Ann Surg Oncol 8, 319–327 (2001). https://doi.org/10.1007/s10434-001-0319-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0319-7

Keywords:

Search

Navigation